Hanseens et al. [59]reported 23.6% SRSF2, 5.6% SF3B1 and 2.7% U2AF1 mutations in a group of 72 mastocytosis patients and their presence was mutually exclusive. This evidence concerns the gene SRSF2 and mastocytosis.